| Primary |
| Schizophrenia |
21.7% |
| Mental Disorder |
15.2% |
| Schizoaffective Disorder |
8.7% |
| Anxiety Disorder |
6.5% |
| Bipolar Disorder |
4.3% |
| Depression |
4.3% |
| Drug Use For Unknown Indication |
4.3% |
| Psychotic Disorder |
4.3% |
| Schizophrenia, Catatonic Type |
4.3% |
| Schizophrenia, Paranoid Type |
4.3% |
| Spindle Cell Sarcoma |
4.3% |
| Antibiotic Prophylaxis |
2.2% |
| Epilepsy |
2.2% |
| Hypertension |
2.2% |
| Hypertensive Cardiomyopathy |
2.2% |
| Mania |
2.2% |
| Nervous System Disorder |
2.2% |
| Nervousness |
2.2% |
| Surgery |
2.2% |
|
| Neuroleptic Malignant Syndrome |
10.7% |
| Blood Creatine Phosphokinase Increased |
7.1% |
| Hyponatraemia |
7.1% |
| Medication Error |
7.1% |
| Neutrophil Count Decreased |
7.1% |
| Parkinsonism |
7.1% |
| Pulmonary Embolism |
7.1% |
| Dyskinesia |
3.6% |
| Dyspnoea |
3.6% |
| Electrocardiogram Qt Prolonged |
3.6% |
| Eye Disorder |
3.6% |
| Liver Disorder |
3.6% |
| Long Qt Syndrome |
3.6% |
| Muscle Rigidity |
3.6% |
| Muscle Twitching |
3.6% |
| Muscular Weakness |
3.6% |
| Oculogyric Crisis |
3.6% |
| Oromandibular Dystonia |
3.6% |
| Oropharyngeal Spasm |
3.6% |
| Pharmaceutical Product Complaint |
3.6% |
|
| Secondary |
| Schizophrenia |
19.7% |
| Product Used For Unknown Indication |
18.3% |
| Drug Use For Unknown Indication |
9.9% |
| Prophylaxis |
7.6% |
| Schizophrenia, Paranoid Type |
7.1% |
| Schizoaffective Disorder |
5.3% |
| Tourette's Disorder |
5.0% |
| Foetal Exposure During Pregnancy |
4.8% |
| Depression |
4.0% |
| Hallucination, Auditory |
2.9% |
| Psychotic Disorder |
2.9% |
| Anxiety |
2.7% |
| Acute Psychosis |
2.1% |
| Mental Disorder |
1.5% |
| Bipolar Disorder |
1.3% |
| Tic |
1.3% |
| Sedative Therapy |
1.1% |
| Appetite Disorder |
0.8% |
| Epilepsy |
0.8% |
| Oropharyngeal Pain |
0.8% |
|
| Weight Increased |
17.9% |
| Drug Interaction |
7.5% |
| Dyskinesia |
6.0% |
| Emotional Disorder |
6.0% |
| Vertigo |
6.0% |
| Vomiting |
6.0% |
| Inappropriate Antidiuretic Hormone Secretion |
4.5% |
| Myocardial Infarction |
4.5% |
| Neuroleptic Malignant Syndrome |
4.5% |
| Neutropenia |
4.5% |
| Respiratory Alkalosis |
4.5% |
| Tinnitus |
4.5% |
| Body Mass Index Increased |
3.0% |
| Cardiac Arrest |
3.0% |
| Gestational Diabetes |
3.0% |
| Intentional Drug Misuse |
3.0% |
| Memory Impairment |
3.0% |
| Neonatal Asphyxia |
3.0% |
| Pancreatitis Haemorrhagic |
3.0% |
| Tachycardia |
3.0% |
|
| Concomitant |
| Schizophrenia |
15.4% |
| Product Used For Unknown Indication |
11.4% |
| Drug Use For Unknown Indication |
10.2% |
| Depression |
9.2% |
| Tourette's Disorder |
8.8% |
| Bipolar Disorder |
6.2% |
| Psychotic Disorder |
6.0% |
| Schizophrenia, Paranoid Type |
5.7% |
| Anxiety |
5.4% |
| Schizoaffective Disorder |
4.2% |
| Hypertension |
3.1% |
| Smoking Cessation Therapy |
2.6% |
| Insomnia |
2.5% |
| Extrapyramidal Disorder |
2.0% |
| Mental Disorder |
1.8% |
| Affective Disorder |
1.5% |
| Major Depression |
1.4% |
| Pulmonary Hypertension |
0.9% |
| Weight Control |
0.9% |
| Antidepressant Therapy |
0.8% |
|
| Weight Increased |
21.8% |
| Granulocytopenia |
10.1% |
| Type 2 Diabetes Mellitus |
9.2% |
| Vomiting |
7.6% |
| Overdose |
5.0% |
| Tardive Dyskinesia |
5.0% |
| Tremor |
4.2% |
| Urinary Tract Infection |
4.2% |
| Pain In Extremity |
3.4% |
| Pancreatitis |
3.4% |
| Thinking Abnormal |
3.4% |
| Confusional State |
2.5% |
| Convulsion |
2.5% |
| Drug Eruption |
2.5% |
| Drug Ineffective |
2.5% |
| Hallucination |
2.5% |
| Interstitial Lung Disease |
2.5% |
| Leukopenia |
2.5% |
| Obesity |
2.5% |
| Pancreatitis Haemorrhagic |
2.5% |
|
| Interacting |
| Mental Disorder |
80.0% |
| Depressed Mood |
10.0% |
| Paranoia |
10.0% |
|
| Throat Tightness |
50.0% |
| Drug Interaction |
25.0% |
| Tremor |
25.0% |
|
